Eva Andersson

Eva Andersson

Auto-generated profile, based on publicly available information

Eva Andersson

Department of Physical Activity and Health, Swedish School of Sport and Health Sciences, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2026 in Archives of Osteoporosis
Verified
Journal Article
Open access
PDF file
PLPeter W. S. Lindberg
Peter W. S. Lindberg
KMKristin Moystad Michelet
Kristin Moystad Michelet
CAChristina Kaijser Alin
Christina Kaijser Alin
EAEva Andersson
Eva Andersson
AKAnn-Charlotte Grahn Kronhed
Ann-Charlotte Grahn Kronhed
HSHelena Salminen
Helena Salminen
Summary: The efficacy of OsteoStrong® (OS) on bone strength is limited, and how it compares to dynamic multicomponent exercise (DME) is unknown. In this randomized controlled trial, the effect of OS on bone material strength index (BMSi) in older women was non-inferior to that of DME. No significant interaction between treatment and time was observed in any measured outcomes, indicating no meaningful difference between the intervention groups. Although the OsteoStrong® intervention met the pre-specified non-inferiority margin compared to the DME group, the lack of efficacy of the DME intervention on BMSi limits the interpretation of this finding. Purpose: The aim of this study was to investigate whether the effect of using OS was non-inferior to DME for the primary outcome of BMSi in older women. Methods: Women aged 65–79 years with osteopenia or osteoporosis were randomized to 9 months of once-weekly OS (20 min) or twice-weekly DME (60 min/session). A total of 194 women (OS, 97; DME, 97), median age 70 years, participated in the trial. The primary outcome was BMSi measured with impact microindentation at the tibia. A pre-specified non-inferiority margin of BMSi −5.2 was applied to determine whether the intervention’s efficacy was not clinically worse than the comparator within an acceptable threshold. The secondary outcomes were bone mineral density (BMD) and bone markers (S-CTX, S-P1NP, S-BALP, and S-sclerostin). Results: At the 9-month follow-up, there were no significant differences between the groups in any of the outcomes. The mean between‑group difference in BMSi was 1.16, with a 95% confidence interval ranging from − 1.51 to 3.82. Since the lower limit of the confidence interval (− 1.51) did not cross the predefined non‑inferiority margin of − 5.2, non‑inferiority was established. There was a significant increase in BMSi by 2.9% in the OS group (from 73.9 ± 9.5 to 76 ± 9.4, p = 0.025), and lumbar spine BMD by 0.8% in the DME group (from 0.866 g/cm 2 ± 0.13 to 0.872 g/cm 2 ± 0.13, p = 0.016). Changes in femoral neck BMD were not significant. There were no significant within- or between-group differences in any of the bone markers at 3 and 9 months. Conclusions: Based on these findings, the effect of OsteoStrong® on BMSi in older women was non-inferior to that of dynamic multicomponent exercise. No significant interaction between treatment and time was observed in any measured outcomes, indicating no meaningful difference between the intervention groups. Although the OsteoStrong® intervention met the pre-specified non-inferiority margin compared to the DME group, the lack of efficacy of the DME intervention on BMSi limits the interpretation of this finding.

27 November 2025 in Cognitive Behaviour Therapy
Verified
Journal Article
Open access
SSSilje Haukenes Stavestrand
Silje Haukenes Stavestrand
KSKristine Sirevåg
Kristine Sirevåg
INInger Hilde Nordhus
Inger Hilde Nordhus
KSKarsten Specht
Karsten Specht
HMHelge Molde
Helge Molde
AHAnders Hovland
Anders Hovland
Generalized anxiety disorder (GAD) is a severe and prevalent disorder among older adults. Cognitive behaviour therapy (CBT) is recommended treatment for GAD, but older adults benefit less than younger peers. Physical exercise has been suggested to improve treatment efficacy. We aimed to determine the efficacy of augmenting CBT with physical exercise for older adults with GAD. This randomised controlled trial included 50 participants (mean [SD] age 66.52 [4.09] years; 39 [78%] female) with GAD. Participants received individual CBT and were randomised to either physical exercise or telephone attention placebo. The main outcome measure was self-reported worry on the Penn State Worry Questionnaire (PSWQ). Secondary outcome measures were clinician-rated remission and self-reported symptoms of anxiety, depression, and quality of life. Although the interaction between time and condition was statistically nonsignificant, moderation analysis revealed that this interaction was significant for participants with low treatment credibility to CBT at baseline. Participants randomised to physical exercise were five times more likely to achieve reliable long-term worry-reduction than placebo control. We found significant differences in favour of physical exercise for secondary measures of depression and anxiety. Participants with better cognitive inhibition at baseline were more likely to achieve clinician-rated remission. Findings suggest that physical exercise augments CBT for older adults with GAD.

5 July 2026 in Aging Clinical and Experimental Research
Verified
Journal Article
Open access
PLPeter W.S. Lindberg
Peter W.S. Lindberg
HLHans Ranch Lundin
Hans Ranch Lundin
EAEva Andersson
Eva Andersson
AKAnn-Charlotte Grahn Kronhed
Ann-Charlotte Grahn Kronhed
ETEva Toth-Pal
Eva Toth-Pal
HSHelena Salminen
Helena Salminen
Background: Limited research exists on the effects of OsteoStrong on physical function in older women. Aim: This randomized controlled trial aimed to evaluate and compare the effects of OsteoStrong (OS) and dynamic multicomponent exercise (DME) on functional outcomes in older women with osteopenia or osteoporosis. Methods: A total of 194 women aged 65–79 years with a T-score of ≤–1.0 at the hip and/or spine were randomized to nine months of either OS (once weekly, 20 min) or DME (twice weekly, 60 min). Outcomes included measures of muscle strength (hand grip and back strength), back and trunk endurance, mobility (sit-to-stand tests, gait speed, Timed Up and Go), and balance (one-leg standing time, tandem standing, tandem walking). Measurements were conducted at baseline and again at nine months. Results: Both OS and DME showed significant improvements in grip strength, back strength, isometric trunk flexion endurance, gait speed 30 m (m/sec), 5 sit-to-stand (sec) and 50 sit-to-stand speed (n/sec) with no significant between-group differences. DME resulted in greater improvements in gait speed 30 m (+ 7.1% vs. +3.2%, p = 0.001), isometric trunk extension (+ 27.6% vs. +4.4%, p = 0.007), and one-leg standing balance (right leg: +13.1% vs. -2.1%, p = 0.001; left leg: +13.3% vs. -2.4%, p = 0.001) compared to OS. Conclusion: These findings suggest that while both OS and DME improve physical function in older women with osteopenia or osteoporosis, DME provides superior benefits in gait speed, back muscle endurance, and balance. These findings should be interpreted with caution, as they are based on secondary outcomes.

17 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
OHOscar Horwath
Oscar Horwath
MMMarcus Moberg
Marcus Moberg
NHNathan Hodson
Nathan Hodson
SESebastian Edman
Sebastian Edman
MJMats Johansson
Mats Johansson
WAWilliam Apró
William Apró
Background: Sarcopenia is thought to be underlined by age-associated anabolic resistance and dysregulation of intracellular signalling pathways. However, it is unclear whether these phenomena are driven by ageing per se or other confounding factors. Methods: Lean and healthy young (n=10, 22 ± 3 yrs, BMI; 23.4 ± 0.8 kg/m 2 ) and old men (n=10, 70 ± 3 yrs, BMI; 22.7 ± 1.3 kg/m 2 ) performed unilateral resistance exercise followed by intake of essential amino acids (EAA). Muscle biopsies were collected from the rested and the exercised leg before, immediately after, as well as 60 and 180 minutes after EAA intake. Muscle samples were analyzed for amino acid concentrations, muscle protein synthesis (MPS) and associated anabolic signaling. Results: Following exercise, peak plasma levels of EAA and leucine were similar between groups, but the area under the curve was ∼11% and ∼28% lower in Young (p<0.01). Absolute levels of muscle EAA and leucine peaked 60 min after exercise, with ∼15 and ∼21 % higher concentrations in the exercising leg (p<0.01) but with no difference between groups. MPS increased in both the resting (∼ 0.035%·h -1 to 0.056%·h -1 , p<0.05) and exercising leg (∼ 0.035%·h -1 to 0.083%·h -1 , p<0.05) with no difference between groups. Phosphorylation of S6K1 Thr389 increased to a similar extent in the exercising leg in both groups but was 2.8-fold higher in the resting leg of Old at the 60 min timepoint (p<0.001). Phosphorylation of 4E-BP1 Ser65 increased following EAA intake and exercise, but differences between legs were statistically different only at 180 min (p<0.001). However, phosphorylation of this site was on average 78% greater across all timepoints in Old (p<0.01). Phosphorylation of eEF2 Thr56 was reduced (∼ 66 and 39%) in the exercising leg at both timepoints after EAA intake and exercise, with no group differences (p<0.05). However, phosphorylation at this site was reduced by ∼ 27% also in the resting leg at 60 min, an effect that was only seen in Old (p<0.01). Total levels of Rheb (∼ 45%), LAT1 (∼ 31%) and Rag B (∼ 31%) were higher in Old (p<0.001). Conclusion: Lean and healthy old men do not manifest AR as evidenced by potent increases in MPS and mTORC1 signalling following EAA intake and exercise. Maintained anabolic sensitivity with age appears to be a function of a compensatory increase in basal levels of proteins involved in anabolic signalling. Therefore, our results suggest that age per se does not appear to cause AR in human skeletal muscle.

11 July 2019 in Open Heart
Verified
Journal Article
Open access
PDF file
JMJosephine Muhrbeck
Josephine Muhrbeck
EGElif Gunyeli
Elif Gunyeli
EAEva Andersson
Eva Andersson
MAMahbubul Alam
Mahbubul Alam
VFViveka Frykman
Viveka Frykman
JSJohanna Sjoblom
Johanna Sjoblom
Objective A reduction in left ventricular ejection fraction (EF) remains the strongest indicator of increased risk of sudden cardiac death after an acute myocardial infarction (AMI). Guidelines recommend that patients with an EF ≤35%, 6–12 weeks after AMI should be considered for implantable cardioverter defibrillator (ICD) therapy. Stress echocardiography is a safe method to detect viability in a stunned myocardium. The purpose of this study was to investigate if stress echocardiography early after AMI could identify ICD candidates before discharge. Methods Ninety-six patients with EF ≤40% early after AMI were prospectively included in a cohort study, and investigated by baseline and stress echocardiography before discharge. Follow-up echocardiography was performed after 3 months. EF, mitral annular plane systolic excursion (MAPSE) and peak systolic velocity (PSV) were determined for each examination. Results There were 80 (83%) patients who completed the baseline, stress and follow-up echocardiography. Among them there were 32 (40%) patients who met the ICD criteria of EF ≤35% at 3 months. For these patients, EF, MAPSE and PSV were significantly lower than for those patients who recovered. The area under the receiver operating characteristic curve (AUC) was 85% (95% CI 0.74 to 0.94) for baseline EF to predict non-recovery. None of the other variables had a higher AUC. Conclusion Patients who met the ICD criteria of EF ≤35% at 3 months after myocardial infarction had lower EF, MAPSE and PSV on baseline and stress echocardiograph before discharge. Stress echocardiography did not add additional value in predicting non-recovery.

13 August 2026 in Acta Paediatrica
Verified
Journal Article
Open access
PDF file
GAGosta Alfven
Gosta Alfven
EAEva Andersson
Eva Andersson
Click on the article title to read more.